Covered recipient · General Payments record
RATNA K BHAVARAJU SANKA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neuromuscular Medicine
General Payments · PY2018–2024
$58,020.29
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $4,062.50 | 3 |
| Food and Beverage | $470.06 | 7 |
| Travel and Lodging | $453.23 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ARGENX US, INC. | $4,062.50 | 3 |
| CSL Behring | $518.23 | 3 |
| UCB, Inc. | $259.04 | 2 |
| Amgen Inc. | $124.18 | 2 |
| Kedrion Biopharma, Inc. | $21.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $27.16 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115451116 | CMS |
| Amgen Inc. | $97.02 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115451120 | CMS |
| ARGENX US, INC. | $1,250.00 | 05/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142113247 | CMS |
| ARGENX US, INC. | $1,250.00 | 07/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142113315 | CMS |
| ARGENX US, INC. | $1,562.50 | 09/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142126723 | CMS |
| CSL Behring | $453.23 | 09/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1134657497 | CMS |
| CSL Behring | $29.00 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134657499 | CMS |
| CSL Behring | $36.00 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134657501 | CMS |
| Kedrion Biopharma, Inc. | $21.84 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125861774 | CMS |
| UCB, Inc. | $124.99 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143037141 | CMS |
| UCB, Inc. | $134.05 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143037143 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.